PGE1 as Additive Anticoagulant in ECMO-Therapy
Stopped After completion of pilot study (n=50) no effect on primary outcome and limited feasibility of recruitment and study procedures
Conditions
- Respiratory Distress Syndrome, Adult
- Extracorporeal Membrane Oxygenation
Interventions
- DRUG: Alprostadil
- DRUG: 0.9% sodium chloride solution
Sponsor
Thomas Staudinger